Nε Functionalization of Metal and Organic Protected L‐Histidine for a Highly Efficient, Direct Labeling of Biomolecules with [Tc(OH2)3(CO)3]+
- 5 May 2003
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 9 (9), 2053-2061
- https://doi.org/10.1002/chem.200204445
Abstract
Two different pathways for the introduction of an acetyl group at Nε in a Nα, Nδ, and -COO protected histidine to afford Nε-(CH2COOH)-histidine derivative 7 b are presented. The purpose of this study is the coupling of 7 b to amino groups in bioactive molecules such as peptides. After full deprotection of such a bioconjugate, histidine provides three coordination sites which efficiently coordinate to [99mTc(OH2)3(CO)3]+ or [Re(OH2)3(CO)3]+ in a facial geometry. This allows the development of novel radiopharmaceuticals. Selective derivatization at the Nε position has conveniently been achieved by concomitant protection of Nα and Nδ with a carbonyl group forming a six-membered urea. Cyclic urea ring opening with Fm-OH, coupling of phenylalanine as a model to 7 b through its primary amine and removing of all protecting groups in one step gave a histidine derivative of phenylalanine which could be labeled at 10−5 M with 99mTc in very high yield and even in about 50 % yield at 10−6 M. The Xray structure of a complex with [Re(CO)3]+ in which anilin is coupled to 7 b confirms the facial arrangement of histidine. A second pathway applies directly the [Re(CO)3]+ moiety as a protecting group. This is one of the rare examples in which a metal fragment is used as a protecting group for organic functionalities. The coordination to histidine protects the Nα, Nδ and COO group in one single step, subsequent alkylation with BrCH2COOH(R) at Nε, coupling to phenylalanine and oxidative deprotection of [Re(CO)3]+ to [ReO4]− gave the corresponding bioconjugate in which histidine is coupled to phenylalanine through an acetylamide at Nε. Both methods offer convenient pathways to introduce histidine in a biomolecule under retention of its three coordination sites. The procedures are adaptable to any biomolecule with pendant amines and allow the development of novel radiopharmaceuticals or inversed peptides.Keywords
This publication has 39 references indexed in Scilit:
- Surfactant protein B labelled with [99mTc(CO)3(H2O)3]+ retains biological activity in vitroNuclear Medicine and Biology, 2001
- Labeling of Biomolecules for Medicinal Applications—Bioorganometallic Chemistry at Its BestAngewandte Chemie International Edition, 2001
- In vitro and in vivo evaluation of new radiolabeled neurotensin(8–13) analogues with high affinity for NT1 receptorsNuclear Medicine and Biology, 2001
- Variable temperature electrochemistry as a powerful method for conformational investigations on the fluxional organometallic complex Mo(His-Nɛ-C2H4CO2Me)(η-allyl)(CO)2 (His = Nδ, N,O-l-histidinate)Chemical Communications, 2001
- The Mo(η-allyl)(CO)2 Moiety as a Robust Marker Group in Bioorganometallic Chemistry. Unusual Crystal Structure of the Phenylalanine Derivative Mo(C5H4-CO-Phe-OMe)(η-allyl)(CO)2Organometallics, 2000
- SIR97: a new tool for crystal structure determination and refinementJournal of Applied Crystallography, 1999
- Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systemsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Synthesis and reactivity of [NEt4]2[ReBr3(CO)3]. Formation and structural characterization of the clusters [NEt4][Re3(µ3-OH)(µ-OH)3(CO)9] and [NEt4][Re2(µ-OH)3(CO)6] by alkaline titrationJ. Chem. Soc., Dalton Trans., 1994
- Synthesis and characterization of a pentadentate Schiff base N3O2 ligand and its neutral technetium(V) complex. X-ray structure of {N,N'-3-azapentane-1,5-diylbis(3-(1-iminoethyl)-6-methyl-2H-pyran-2,4(3H)-dionato)(3-)-O,O',N,N',N''}oxotechnetium(V)Inorganic Chemistry, 1991
- New brain perfusion imaging agents based on technetium-99m bis(aminoethanethiol) complexes: stereoisomers and biodistributionJournal of Medicinal Chemistry, 1989